ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,084.61
-0.26%
Dow Jones
42,840.26
1.18%
Gold vs US Dollar
2,623.175
0.00%
Brent Oil
72.72
0.00%
Bitcoin
98,457.86
0.71%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Australia
  5. ASX
  6. Donaco International Ltd (DNA)

  7. Donaco International Ltd (DNA) News

Donaco (DNA)

Donaco International Ltd
Date:
Sort by:
 Showing the most relevant articles for your search:ASX:DNA
DateTimeSourceHeadlineSymbolCompany
10/11/201523:52The Motley FoolPacker backs Crown Resorts Ltd with $200 million betASX:DNADonaco International Ltd
27/03/200915:13Dow Jones NewsUPDATE: FDA 'Unclear' If Avastin Data Backs Expanded ApprovalLSE:DNAGenentech Inc. (Delisted 3/27/09)
27/03/200914:35Dow Jones NewsFDA 'Unclear' If Genentech Drug Data Backs Expanded ApprovalLSE:DNAGenentech Inc. (Delisted 3/27/09)
26/03/200909:23Dow Jones NewsUPDATE: Roche Effectively Seals $46.8 Billion Genentech TakeoverLSE:DNAGenentech Inc.
26/03/200907:05Dow Jones NewsRoche Completes Genentech Takeover, Holds 93.2%LSE:DNAGenentech Inc.
26/03/200906:37Dow Jones NewsRoche Completes Tender Offer For Genentech, Holds 93.2%LSE:DNAGenentech Inc.
25/03/200912:44Dow Jones News2nd UPDATE: Ethos Recommends UBS Holders Reject New Pay PlanLSE:DNAGenentech Inc.
25/03/200910:43Dow Jones NewsUPDATE: Ethos Recommends UBS Holders Reject New Pay Plan At AGMLSE:DNAGenentech Inc.
24/03/200918:08Dow Jones NewsRoche Says RiskMetrics Backs Genentech Takeover At $95/ShareLSE:DNAGenentech Inc.
19/03/200917:09Dow Jones NewsEU Panel Backs Novartis' Glivec In Kit-positive GISTLSE:DNAGenentech Inc.
18/03/200913:55Dow Jones NewsRoche Shares Down On Actemra; Herceptin Success Of Little HelpLSE:DNAGenentech Inc.
18/03/200907:16Dow Jones NewsRoche's Herceptin Extends Life In Aggressive Stomach CancerLSE:DNAGenentech Inc.
18/03/200906:33Dow Jones NewsRoche: Herceptin Prolongs Life In Stomach CancerLSE:DNAGenentech Inc.
18/03/200904:32Dow Jones NewsUPDATE: Chugai,Roche Face Arthritis Drug Side Effect SetbackLSE:DNAGenentech Inc.
18/03/200901:05Dow Jones NewsChugai:Undeniable Actemra Side Effects Tied To Patient DeathsLSE:DNAGenentech Inc.
17/03/200922:54Dow Jones NewsBiotechnology Group Praises Biologic Drugs BillLSE:DNAGenentech Inc.
17/03/200920:29Dow Jones News5th UPDATE: Pfizer Sells $13.5 Billion Bond Offering TuesdayLSE:DNAGenentech Inc.
17/03/200919:25Dow Jones News4th UPDATE: Pfizer Sells $13.5 Billion Bond Offering TuesdayLSE:DNAGenentech Inc.
17/03/200917:53Dow Jones News3rd UPDATE: Pfizer Launches $13.5 Billion Bond Offer; Pricing TuesdayLSE:DNAGenentech Inc.
17/03/200917:01Dow Jones News2ndUPDATE:Pfizer Launches $13.5 Billion Bond Offering For Pricing TuesdayLSE:DNAGenentech Inc.
17/03/200916:13Dow Jones NewsUPDATE:Pfizer Launches $13.5 Billion Bond Offering For Pricing TuesdayLSE:DNAGenentech Inc.
16/03/200920:57Dow Jones NewsMARKET SNAPSHOT: Corporate Cash Reserves, Cheap Stocks Could Trigger More M&ALSE:DNAGenentech Inc.
16/03/200918:49Dow Jones NewsMARKET SNAPSHOT: Corporate Cash Warchests, Cheap Stocks Could Trigger More M&ALSE:DNAGenentech Inc.
16/03/200906:37Dow Jones NewsRoche Acquires Innovatis AG For EUR15 MillionLSE:DNAGenentech Inc.
13/03/200912:45Dow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsLSE:DNAGenentech Inc.
12/03/200920:42Dow Jones NewsGenentech-Roche Deal Shows Attraction Of Biotech AssetsLSE:DNAGenentech Inc.
12/03/200919:15Dow Jones NewsUS Antitrust Review May Not Pose Threat To Drug Co MergersLSE:DNAGenentech Inc.
12/03/200914:06Dow Jones NewsUPDATE: Gilead To Buy CV Therapeutics For $1.4 BillionLSE:DNAGenentech Inc.
12/03/200911:10Dow Jones News4th UPDATE: Roche Seals $46.8 Billion Genentech DealLSE:DNAGenentech Inc.
12/03/200908:32Dow Jones News3rd UPDATE: Roche Seals $46.8 Billion Genentech DealLSE:DNAGenentech Inc.
 Showing the most relevant articles for your search:ASX:DNA

Your Recent History

BIT
BNP
BNP Paribas
AMEX
BMTX
BM Technologies
EU
RINAB
Vilmorin & Compagnie SA ...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    Go Ad-Free

    Subscribe to Ad free and enjoy an ad-free experience

    No Ads

    Try Now

    Keep the Ads